| 1 |
34504225 | Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors. | 2021 Sep 9 |
1 |
| 2 |
34642380 | Publisher Correction: Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors. | 2021 Oct 12 |
1 |
| 3 |
31615316 | Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test? | 2020 Dec |
1 |
| 4 |
30578970 | SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region. | 2019 Feb |
1 |
| 5 |
30964811 | Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy? | 2019 Jul |
1 |
| 6 |
28288508 | Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy. | 2018 Sep |
3 |
| 7 |
30052856 | Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease. | 2018 Nov 15 |
1 |
| 8 |
24464437 | Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy. | 2015 Jan |
1 |
| 9 |
27708877 | Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug? | 2014 Jun |
3 |
| 10 |
21482342 | [Pulmonary sarcoidosis developing during treatment with etanercept]. | 2011 Mar |
1 |
| 11 |
21125170 | Use of the abatacept in a patient with psoriatic arthritis. | 2010 May-Jun |
1 |
| 12 |
18208824 | Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. | 2008 Feb |
1 |
| 13 |
17332973 | Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. | 2007 Nov |
3 |